Retail prices for 39 new drug formulations have been fixed under the DPCO, 2013, to improve access to affordable medicines ...

A law passed last year requires CT to petition the federal government for cheaper GLP-1 drugs. But the state is not moving ...

Glenmark Pharmaceuticals will pay nearly $29.7 million to resolve allegations that it participated in a coordinated scheme to inflate generic drug prices and reduce competition. The settlement, ...

India is considering stronger regulatory data protection for new medicines. The country's generic pharmaceutical industry has ...

Millions of individuals worldwide have been treated for diabetes with regular insulin injections for decades. However, ...

Mubadala Bio has announced the launch of new hemodialysis products through its subsidiary Wellpharma, one of its Abu ...

We're honoring America's 250th anniversary by rounding up the most life-changing medical inventions from right here in the ...

Minerals such as magnesium, zinc, iodine, selenium and iron are foundational to immune function, yet subclinical deficiencies ...

A pilot study conducted by UT's Health Sciences College of Pharmacy and Kroger Health found that standardized A1C testing in community pharmacies improved access to diabetes screening, and Kroger has ...

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...

A novel plasmid-based immunotherapy was safe and well tolerated among adults with type 1 diabetes autoantibodies, according ...

Gamblers can now bet on how experimental drugs will perform in clinical trials—and if they’ll get FDA approval.